8 USD
+0.47 (+6.24%)
CCRN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While CCRN has a great health rating, its profitability is only average at the moment. CCRN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
CCRN had positive earnings in the past year.
CCRN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CCRN reported negative net income in multiple years.
CCRN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CCRN has a Return On Assets of -2.91%. This is in the lower half of the industry: CCRN underperforms 61.39% of its industry peers.
CCRN has a Return On Equity of -3.84%. This is comparable to the rest of the industry: CCRN outperforms 48.51% of its industry peers.
The Return On Invested Capital of CCRN (0.98%) is comparable to the rest of the industry.
CCRN had an Average Return On Invested Capital over the past 3 years of 15.05%. This is significantly above the industry average of 9.22%.
The 3 year average ROIC (15.05%) for CCRN is well above the current ROIC(0.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.91% | ||
| ROE | -3.84% | ||
| ROIC | 0.98% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
1.3 Margins
CCRN has a Operating Margin (0.56%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CCRN has declined.
CCRN has a Gross Margin (20.19%) which is in line with its industry peers.
CCRN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.56% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% |
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
CCRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CCRN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CCRN has less shares outstanding
There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CCRN has an Altman-Z score of 4.27. This indicates that CCRN is financially healthy and has little risk of bankruptcy at the moment.
CCRN has a better Altman-Z score (4.27) than 79.21% of its industry peers.
CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.27 |
ROIC/WACC0.11
WACC8.7%
2.3 Liquidity
CCRN has a Current Ratio of 3.45. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.45, CCRN belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
CCRN has a Quick Ratio of 3.45. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.45, CCRN belongs to the best of the industry, outperforming 89.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.45 |
3. Growth
3.1 Past
CCRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -82.86%.
The Earnings Per Share has been growing by 24.57% on average over the past years. This is a very strong growth
The Revenue for CCRN has decreased by -22.14% in the past year. This is quite bad
CCRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.33% yearly.
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
3.2 Future
CCRN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -16.16% yearly.
The Revenue is expected to decrease by -5.63% on average over the next years.
EPS Next Y-68.27%
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
EPS Next 5YN/A
Revenue Next Year-16.68%
Revenue Next 2Y-8.76%
Revenue Next 3Y-5.63%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 66.67, the valuation of CCRN can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as CCRN.
Compared to an average S&P500 Price/Earnings ratio of 26.41, CCRN is valued quite expensively.
Based on the Price/Forward Earnings ratio of 30.46, the valuation of CCRN can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCRN is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.40, CCRN is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.67 | ||
| Fwd PE | 30.46 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCRN indicates a rather cheap valuation: CCRN is cheaper than 89.11% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCRN indicates a rather cheap valuation: CCRN is cheaper than 96.04% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.74 | ||
| EV/EBITDA | 6.25 |
4.3 Compensation for Growth
A cheap valuation may be justified as CCRN's earnings are expected to decrease with -16.16% in the coming years.
PEG (NY)N/A
PEG (5Y)2.71
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
5. Dividend
5.1 Amount
No dividends for CCRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CCRN (12/5/2025, 1:50:58 PM)
8
+0.47 (+6.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.83%
Inst Owner Change-0.6%
Ins Owners5.37%
Ins Owner Change-0.41%
Market Cap262.08M
Revenue(TTM)1.13B
Net Income(TTM)-15.68M
Analysts52.31
Price Target18.44 (130.5%)
Short Float %10.84%
Short Ratio9.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.09%
Min EPS beat(2)-118.38%
Max EPS beat(2)-19.79%
EPS beat(4)1
Avg EPS beat(4)-49.67%
Min EPS beat(4)-118.38%
Max EPS beat(4)5.59%
EPS beat(8)4
Avg EPS beat(8)-23.71%
EPS beat(12)7
Avg EPS beat(12)-12.92%
EPS beat(16)11
Avg EPS beat(16)-6.6%
Revenue beat(2)0
Avg Revenue beat(2)-8.46%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-7.46%
Revenue beat(4)0
Avg Revenue beat(4)-5.87%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-0.73%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)6
Avg Revenue beat(16)-0.91%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-37.1%
EPS NQ rev (3m)-37.1%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-7.5%
Revenue NQ rev (3m)-7.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.67 | ||
| Fwd PE | 30.46 | ||
| P/S | 0.23 | ||
| P/FCF | 5.74 | ||
| P/OCF | 4.83 | ||
| P/B | 0.64 | ||
| P/tB | 1.1 | ||
| EV/EBITDA | 6.25 |
EPS(TTM)0.12
EY1.5%
EPS(NY)0.26
Fwd EY3.28%
FCF(TTM)1.39
FCFY17.43%
OCF(TTM)1.66
OCFY20.7%
SpS34.42
BVpS12.46
TBVpS7.25
PEG (NY)N/A
PEG (5Y)2.71
Graham Number5.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.91% | ||
| ROE | -3.84% | ||
| ROCE | 1.39% | ||
| ROIC | 0.98% | ||
| ROICexc | 1.26% | ||
| ROICexgc | 2.43% | ||
| OM | 0.56% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% | ||
| FCFM | 4.05% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 49.56% | ||
| Cap/Sales | 0.76% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 229.81% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.45 | ||
| Altman-Z | 4.27 |
F-Score5
WACC8.7%
ROIC/WACC0.11
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
EPS Next Y-68.27%
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
Revenue Next Year-16.68%
Revenue Next 2Y-8.76%
Revenue Next 3Y-5.63%
Revenue Next 5YN/A
EBIT growth 1Y-52.34%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year540.8%
EBIT Next 3Y89.71%
EBIT Next 5YN/A
FCF growth 1Y-79.94%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-77.47%
OCF growth 3YN/A
OCF growth 5Y85.29%
CROSS COUNTRY HEALTHCARE INC / CCRN FAQ
What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCRN.
Can you provide the valuation status for CROSS COUNTRY HEALTHCARE INC?
ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.
Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?
CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 4 / 10.
What is the financial health of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
The financial health rating of CROSS COUNTRY HEALTHCARE INC (CCRN) is 10 / 10.